Order Article Reprints

Korakas E, Thymis J, Oikonomou E, Mourouzis K, Kountouri A, Pliouta L, Pililis S, Pavlidis G, Lampsas S, Katogiannis K, et al. Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i. Journal of Clinical Medicine. 2024; 13(24):7497. https://doi.org/10.3390/jcm13247497

Korakas, Emmanouil, John Thymis, Evangelos Oikonomou, Konstantinos Mourouzis, Aikaterini Kountouri, Loukia Pliouta, Sotirios Pililis, George Pavlidis, Stamatios Lampsas, Konstantinos Katogiannis, and et al. 2024. "Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i" Journal of Clinical Medicine 13, no. 24: 7497. https://doi.org/10.3390/jcm13247497

Korakas, E., Thymis, J., Oikonomou, E., Mourouzis, K., Kountouri, A., Pliouta, L., Pililis, S., Pavlidis, G., Lampsas, S., Katogiannis, K., Palaiodimou, L., Tsivgoulis, G., Siasos, G., Ikonomidis, I., Raptis, A., & Lambadiari, V. (2024). Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i. Journal of Clinical Medicine, 13(24), 7497. https://doi.org/10.3390/jcm13247497